162 related articles for article (PubMed ID: 35128175)
1. Highlight of potential impact of new viral genotypes of SARS-CoV-2 on vaccines and anti-viral therapeutics.
Ghorbani A; Samarfard S; Jajarmi M; Bagheri M; Karbanowicz TP; Afsharifar A; Eskandari MH; Niazi A; Izadpanah K
Gene Rep; 2022 Mar; 26():101537. PubMed ID: 35128175
[TBL] [Abstract][Full Text] [Related]
2. Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike.
Trigueiro-Louro J; Correia V; Figueiredo-Nunes I; Gíria M; Rebelo-de-Andrade H
Comput Struct Biotechnol J; 2020; 18():2117-2131. PubMed ID: 32913581
[TBL] [Abstract][Full Text] [Related]
3. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
4. Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.
Hassanin AA; Haidar Abbas Raza S; Ahmed Ujjan J; Aysh ALrashidi A; Sitohy BM; Al-Surhanee AA; Saad AM; Mohamed Al-Hazani T; Osman Atallah O; Al Syaad KM; Ezzat Ahmed A; Swelum AA; El-Saadony MT; Sitohy MZ
Saudi J Biol Sci; 2022 Apr; 29(4):1981-1997. PubMed ID: 34924802
[TBL] [Abstract][Full Text] [Related]
5. Minireview of progress in the structural study of SARS-CoV-2 proteins.
Zhu G; Zhu C; Zhu Y; Sun F
Curr Res Microb Sci; 2020 Sep; 1():53-61. PubMed ID: 33236001
[TBL] [Abstract][Full Text] [Related]
6. Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses
Vishwakarma P; Yadav N; Rizvi ZA; Khan NA; Chiranjivi AK; Mani S; Bansal M; Dwivedi P; Shrivastava T; Kumar R; Awasthi A; Ahmed S; Samal S
Front Immunol; 2021; 12():613045. PubMed ID: 33841395
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive overview of identified mutations in SARS CoV-2 spike glycoprotein among Iranian patients.
Eslami S; Glassy MC; Ghafouri-Fard S
Gene; 2022 Mar; 813():146113. PubMed ID: 34896524
[TBL] [Abstract][Full Text] [Related]
8. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
Zhu Y; Yu D; Yan H; Chong H; He Y
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
[TBL] [Abstract][Full Text] [Related]
9. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
[TBL] [Abstract][Full Text] [Related]
10. A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern.
Xing L; Xu X; Xu W; Liu Z; Shen X; Zhou J; Xu L; Pu J; Yang C; Huang Y; Lu L; Jiang S; Liu S
Viruses; 2022 Mar; 14(3):. PubMed ID: 35337003
[TBL] [Abstract][Full Text] [Related]
11. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
12. Quasi-species nature and differential gene expression of severe acute respiratory syndrome coronavirus 2 and phylogenetic analysis of a novel Iranian strain.
Ghorbani A; Samarfard S; Ramezani A; Izadpanah K; Afsharifar A; Eskandari MH; Karbanowicz TP; Peters JR
Infect Genet Evol; 2020 Nov; 85():104556. PubMed ID: 32937193
[TBL] [Abstract][Full Text] [Related]
13. Severe acute respiratory syndrome coronavirus 2 variants-Possibility of universal vaccine design: A review.
Yoon E; Kim D; Jeon H; Kwon Y; Jang Y; Kim S; Hwang KY
Comput Struct Biotechnol J; 2022; 20():3533-3544. PubMed ID: 35765543
[TBL] [Abstract][Full Text] [Related]
14. Adaptive evolution of the spike gene of SARS coronavirus: changes in positively selected sites in different epidemic groups.
Zhang CY; Wei JF; He SH
BMC Microbiol; 2006 Oct; 6():88. PubMed ID: 17020602
[TBL] [Abstract][Full Text] [Related]
15. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.
Liu S; Xiao G; Chen Y; He Y; Niu J; Escalante CR; Xiong H; Farmar J; Debnath AK; Tien P; Jiang S
Lancet; 2004 Mar; 363(9413):938-47. PubMed ID: 15043961
[TBL] [Abstract][Full Text] [Related]
16. Comparative phylogenetic analysis of SARS-CoV-2 spike protein-possibility effect on virus spillover.
Ghorbani A; Samarfard S; Eskandarzade N; Afsharifar A; Eskandari MH; Niazi A; Izadpanah K; Karbanowicz TP
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33885726
[TBL] [Abstract][Full Text] [Related]
17. Analysis of SARS-COV2 spike protein variants among Iraqi isolates.
Sabir DK
Gene Rep; 2022 Mar; 26():101420. PubMed ID: 34754982
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy.
Ridgway H; Chasapis CT; Kelaidonis K; Ligielli I; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Mavromoustakos T; Matsoukas JM
Viruses; 2022 May; 14(5):. PubMed ID: 35632769
[TBL] [Abstract][Full Text] [Related]
19. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
[TBL] [Abstract][Full Text] [Related]
20. The structural basis of accelerated host cell entry by SARS-CoV-2†.
Seyran M; Takayama K; Uversky VN; Lundstrom K; Palù G; Sherchan SP; Attrish D; Rezaei N; Aljabali AAA; Ghosh S; Pizzol D; Chauhan G; Adadi P; Mohamed Abd El-Aziz T; Soares AG; Kandimalla R; Tambuwala M; Hassan SS; Azad GK; Pal Choudhury P; Baetas-da-Cruz W; Serrano-Aroca Á; Brufsky AM; Uhal BD
FEBS J; 2021 Sep; 288(17):5010-5020. PubMed ID: 33264497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]